✦ LIBER ✦

Dose-Intense Cyclophosphamide and Etoposide for Patients with Refractory or High-Risk Non-Hodgkin's Lymphoma

✍ Scribed by Talbot, Jeffrey; Ibom, Valerie K.; Rizzieri, David A.; Barrier, Robert; Niedzwieki, Donna; DeCastro, Carlos M.; Moore, Joseph O.; Buckley, Patrick; Laney, Rhonda; Stevenson, Diane; Brumbaugh, Heather; Gockerman, Jon P.

Book ID: 119935801
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 153 KB
Volume: 5
Category: Article
ISSN: 1526-9655
DOI: 10.3816/clm.2004.n.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose salvage therapy with dose inte

High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma

✍ Vijay, Archana; Duan, Qiuli; Henning, Jan-Willem; Duggan, Peter; Daly, Andrew; S 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 246 KB

Autotransplantation following busulfan,

Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin’s lymphoma

✍ Copelan, E A; Penza, S L; Pohlman, B; Avalos, B R; Goormastic, M; Andresen, S W; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB

Cyclophosphamide, etoposide and carbopla

Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas

✍ Mabed, M; Al-Kgodary, T 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Phase II study of a salvage regimen usin

Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma

✍ Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

High-Dose Carmustine, Etoposide, and Cyc

High-Dose Carmustine, Etoposide, and Cyclophosphamide Followed by Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma

✍ Lisa Y. Law; Sandra J. Horning; Ruby M. Wong; Laura J. Johnston; Ginna G. Laport 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Salvage chemotherapy for relapsed or ref

Salvage chemotherapy for relapsed or refractory non-Hodgkin's lymphoma with a combination of ACES (high-dose Ara C, carboplatin, etoposide and steroids) therapy

✍ N. Niitsu; M. Umeda 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB